Chemical manufacturers face years of regulatory navigation and significant up-front investment when developing disinfectants. Oxidium Technologies eliminates these barriers. We provide established EPA-registered formulations based on proven Aseptrol technology—a chlorine dioxide chemistry developed over decades and developed and commercialized by BASF. The unique formulation allows for rapid ClO₂ generation in a small form-factor that’s stable for years until activated. You maintain brand ownership and market control; we handle technical and regulatory complexity.

This model has enabled established biosafety companies to build market-leading disinfection brands without additional in-house R&D investment. Regardless of the industry or application, Aseptrol allows your team to take advantage of decades of experience and create pure chlorine dioxide, virtually anywhere, in minutes.